Related Experiment Video
Updated: Dec 27, 2025

07:03
Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
Published on: September 23, 2022
2.5K
Extracellular Vesicles of Stem Cells to Prevent BRONJ
J Watanabe1, K Sakai1, Y Urata1
1Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Journal of Dental Research
|March 3, 2020
Summary
Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) show promise in treating bisphosphonate-related osteonecrosis of the jaw (BRONJ). MSC-EVs reduce cellular senescence and inflammation, promoting healing and bone regeneration in BRONJ models.
Area of Science:
- Biomedical research
- Regenerative medicine
- Cell biology
Background:
- Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a serious condition with unclear pathogenesis and treatment options.
- Zoledronic acid (ZOL), a bisphosphonate, is implicated in BRONJ development.
- Extracellular vesicles (EVs) from mesenchymal stem cells (MSC-EVs) are investigated for therapeutic potential in various diseases.
Purpose of the Study:
- To investigate the therapeutic effects of MSC-EVs on zoledronic acid-induced bisphosphonate-related osteonecrosis of the jaw (BRONJ).
- To evaluate the impact of MSC-EVs on cellular senescence and inflammatory responses in BRONJ models.
- To assess MSC-EVs' role in promoting bone regeneration and angiogenesis in BRONJ.
Main Methods:
- In vitro: Zoledronic acid (ZOL) treatment of bone marrow cells and fibroblasts, followed by MSC-EV administration.
- In vivo: A rat model of BRONJ induced by ZOL and tooth extraction, with and without MSC-EV treatment.
- Histological and molecular analyses, including senescence markers (β-galactosidase, p21, pRB), inflammatory cytokines, stem cell markers (Bmi1, Hmga2), and vascular endothelial growth factor (VEGF).
Main Results:
- In vitro, MSC-EVs reduced the number of senescent cells and suppressed senescence-associated genes (p21, pRB) and inflammatory cytokines.
- In vivo, MSC-EV treatment promoted socket healing in BRONJ rats, with reduced senescent cells and inflammation.
- MSC-EVs increased expression of stem cell markers (Bmi1, Hmga2) and vascular endothelial growth factor (VEGF), indicating enhanced angiogenesis and regeneration.
Conclusions:
- MSC-EVs effectively prevent ZOL-induced cellular senescence and reduce inflammation in BRONJ.
- MSC-EV administration promotes wound healing, angiogenesis, and bone regeneration, offering a potential therapeutic strategy for BRONJ.
- MSC-EVs mitigate BRONJ by preventing cellular senescence and chronic inflammation while enhancing regenerative processes.
Related Concept Videos
Mesenchymal Stem Cells
5.4K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.4K
Overview of Exosomes
3.4K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.4K
Osteoclasts in Bone Remodeling
3.7K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.7K

